Health Enterprise Partners

Dave Tamburri and Ezra Mehlman lead the firm as Managing Partners and sit on the Investment Committee. Rick Stowe, a co-founder, remains involved as a Senior Advisor. The managing partners handle day-to-day sourcing, diligence, and portfolio management.

HEP maintains a formal Hospital Advisory Network composed of its limited partners — senior executives at major hospital systems and health plans across the United States. This network surfaces market needs, validates portfolio company products in live clinical and operational environments, and often introduces the firm to founder-led businesses that are pre-revenue or early-commercial but already solving a real health-system pain point.

HEP makes direct equity investments and structures recapitalizations, typically writing checks between $15 million and $40 million. The firm does not market a fund-of-funds strategy and has not publicly disclosed commitments to external private equity managers. Its mandate is concentrated on building a portfolio of company-level positions.

Health Enterprise Partners invests at the growth and expansion stage. Companies typically have validated products and initial commercial traction with health systems or payers. HEP structures both minority and majority recapitalizations and does not compete for seed or early-venture rounds where the commercial use case is still theoretical.

The firm stays out of biotechnology, pharmaceuticals, and medical devices that require FDA pre-market approval. It concentrates strictly on healthcare information technology, tech-enabled services, and outsourced provider services that deliver near-term return on investment for payer and provider organizations.

HEP's limited partner base includes some of the largest not-for-profit hospital systems and health plans in the United States. Rather than treating these LPs as passive capital, HEP integrates them into its Hospital Advisory Network — a formal mechanism that allows portfolio companies to pilot solutions, gain reference accounts, and accelerate enterprise sales within a network that controls substantial healthcare purchasing power.

Yes. HEP runs an operator-in-residence program that places experienced health system and payer executives into portfolio companies. These operators work alongside founders to refine go-to-market strategy and build the commercialization infrastructure needed to sell into large integrated delivery networks.